Femasys Inc
NASDAQ:FEMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BIEM.L.FDLKK Garment Co Ltd
SZSE:002832
|
CN |
|
Z
|
Zhejiang Wansheng Co Ltd
SSE:603010
|
CN |
|
H
|
Haymaker Acquisition Corp 4
NYSE:HYAC
|
US |
|
Wing Fung Group Asia Ltd
HKEX:8526
|
HK |
|
H
|
Hoku Corp
OTC:HOKUQ
|
US |
|
Warby Parker Inc
NYSE:WRBY
|
US |
|
R
|
Reka Industrial Oyj
OMXH:REKA
|
FI |
|
C
|
China Spacesat Co Ltd
SSE:600118
|
CN |
|
O
|
Omesti Bhd
KLSE:OMESTI
|
MY |
|
Beijing Zhidemai Technology Co Ltd
SZSE:300785
|
CN |
|
Grupo Financiero Inbursa SAB de CV
BMV:GFINBURO
|
MX |
|
Exxaro Tiles Ltd
NSE:EXXARO
|
IN |
|
A Metaverse Co
HKEX:1616
|
CN |
|
B
|
Beijing Asiacom Information Technology Co Ltd
SZSE:301085
|
CN |
Femasys Inc
EPS (Diluted)
Femasys Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Femasys Inc
NASDAQ:FEMY
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Femasys Inc
Glance View
Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.
See Also
What is Femasys Inc's EPS (Diluted)?
EPS (Diluted)
-0.5
USD
Based on the financial report for Dec 31, 2025, Femasys Inc's EPS (Diluted) amounts to -0.5 USD.
What is Femasys Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
4%
Over the last year, the EPS (Diluted) growth was 45%. The average annual EPS (Diluted) growth rates for Femasys Inc have been 21% over the past three years , 4% over the past five years .
